Osama Al Assar
About Osama Al Assar
Osama Al Assar serves as the Associate Director and HTA Designated Individual at Adaptimmune, where he has worked since 2021. He has extensive experience in tissue management and research, having held various roles at institutions such as the University of Oxford and the University of Sheffield.
Work at Adaptimmune
Osama Al Assar has been serving as the Associate Director and HTA Designated Individual at Adaptimmune since 2021. In this role, he is responsible for overseeing human tissue management and ensuring compliance with relevant regulations. His tenure at Adaptimmune has included a previous position as Human Tissue Manager from 2018 to 2021, where he managed tissue-related processes and operations. Adaptimmune is located in Abingdon, England, and focuses on developing innovative therapies for cancer treatment.
Education and Expertise
Osama Al Assar has extensive experience in the field of human tissue management and research. He holds a Human Application Licence (number 22682) and a Research Licence (number 12635), indicating his qualifications to handle human tissues for research purposes. His educational background includes significant roles in laboratory management and research, contributing to his expertise in the field.
Background
Before joining Adaptimmune, Osama Al Assar worked at the University of Oxford for 11 years, from 2007 to 2018. During his time there, he held positions as Group Lab Manager and Head of Sample Processing, where he was responsible for managing laboratory operations and sample handling. Additionally, he worked at the University of Sheffield as a Research Scientist and interim group head from 2003 to 2006, further building his foundation in research and management.
Career Progression
Osama Al Assar's career has progressed through various roles in research and laboratory management. Starting as a Research Scientist at the University of Sheffield, he moved to the University of Oxford, where he advanced to managerial positions. His experience culminated in his current role at Adaptimmune, where he continues to apply his knowledge and skills in human tissue management and regulatory compliance.